Published in Neurology on November 17, 2009
Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.08
Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol (2010) 1.26
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.16
Prior medical conditions and the risk of amyotrophic lateral sclerosis. J Neurol (2014) 1.05
Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med (2013) 1.03
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS One (2012) 0.95
Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review. BMC Res Notes (2014) 0.95
A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front Cell Neurosci (2014) 0.91
Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice. PLoS One (2011) 0.85
Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Neuropathol Appl Neurobiol (2015) 0.84
The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis. J Biol Chem (2012) 0.84
HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease. Front Pharmacol (2014) 0.81
Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol (2016) 0.80
Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference? J Clin Neurol (2013) 0.80
Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis. Neurotherapeutics (2015) 0.80
TDP-43/FUS in motor neuron disease: Complexity and challenges. Prog Neurobiol (2016) 0.79
Recent advances in amyotrophic lateral sclerosis. J Neurol (2016) 0.79
A Novel Mathematical Approach to Define the Genes/SNPs Conferring Risk or Protection in Sporadic Amyotrophic Lateral Sclerosis Based on Auto Contractive Map Neural Networks and Graph Theory. Neurol Res Int (2012) 0.78
Body mass index delineates ALS from FTD: implications for metabolic health. J Neurol (2014) 0.77
Amyotrophic lateral sclerosis: a focus on disease progression. Biomed Res Int (2014) 0.77
Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology (2010) 0.77
Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis. PLoS One (2015) 0.76
Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis. Front Cell Neurosci (2017) 0.75
The Association Between Lipoproteins, Disability, and Physical Function Among Older Costa Rican Adults. J Aging Health (2017) 0.75
Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. J Neurol (2016) 0.75
The ribosomal proteins of Escherichia coli. I. Purification of the 30S ribosomal proteins. Biochemistry (1969) 7.47
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis (2010) 3.90
Prevalence of SOD1 mutations in the Italian ALS population. Neurology (2008) 2.60
Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology (2002) 2.34
Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology (2000) 2.24
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene (2000) 2.15
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology (2010) 2.14
Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem (2001) 2.03
Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology (1992) 1.84
A distinct MR imaging phenotype in amyotrophic lateral sclerosis: correlation between T1 magnetization transfer contrast hyperintensity along the corticospinal tract and diffusion tensor imaging analysis. AJNR Am J Neuroradiol (2011) 1.77
Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology (2009) 1.68
Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol (2011) 1.65
High altitude C(4) grasslands in the northern Andes: relicts from glacial conditions? Rev Palaeobot Palynol (2001) 1.49
Influence of ancestral gender on transmission of familial amyotrophic lateral sclerosis. Lancet (1994) 1.46
Neuroborreliosis: a Sardinian case with cerebellar symptoms. Ital J Neurol Sci (1992) 1.40
Pre-clinical applications of transgenic mouse mammary cancer models. Transgenic Res (2002) 1.40
Cesare Lombroso, cortical dysplasia, and epilepsy: keen findings and odd theories. Neurology (2003) 1.38
Progressive genu valgum secondary to a fibrous tether at the distal aspect of the femur. A case report. J Bone Joint Surg Am (1998) 1.38
Focal subcortical reflex myoclonus. A clinical and neurophysiological study. Arch Neurol (1997) 1.38
Longitudinal study on hyperlipidaemia and diet in RDT patients. Minerva Nefrol (1982) 1.38
Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology (2003) 1.37
Perception and action in 'visual form agnosia'. Brain (1991) 1.33
Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol (1995) 1.31
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry (2006) 1.30
Percutaneous endoscopic gastrostomy: a long-term follow-up. Nutrition (1997) 1.29
Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg Med Chem (1999) 1.25
A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology (2007) 1.25
A comparative study of trochanteric fractures treated with the Gamma nail or the proximal femoral nail. Int Orthop (2002) 1.23
Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett (2000) 1.21
A cross sectional study on determinants of quality of life in ALS. J Neurol Neurosurg Psychiatry (2004) 1.15
ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology (2011) 1.14
Caregiver burden and patients' perception of being a burden in ALS. Neurology (2005) 1.13
Cloning, expression and characterization of the 36 KDal Salmonella typhi porin gene in Escherichia coli. Microb Pathog (1987) 1.12
Alcohol use is a risk factor for a first generalized tonic-clonic seizure. The ALC.E. (Alcohol and Epilepsy) Study Group. Neurology (1997) 1.11
Perinatal outcome, placental pathology, and severity of discordance in monochorionic and dichorionic twins. Obstet Gynecol (2001) 1.11
Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer (2011) 1.09
Free amino acids in the cerebrospinal fluid of epileptic subjects. Epilepsia (1974) 1.08
Two different techniques in the rehabilitation treatment of low back pain: a randomized controlled trial. Eura Medicophys (2006) 1.08
The effect of gender on planning: An fMRI study using the Tower of London task. Neuroimage (2006) 1.08
Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology (1991) 1.07
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. Eur J Neurol (2012) 1.07
Downstaging to liver resection by radioembolization: a difficult to reach strategy? Eur J Surg Oncol (2013) 1.06
Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol (2002) 1.06
Developing community-academic partnerships to enhance breast health among rural and Hispanic migrant and seasonal farmworker women. Oncol Nurs Forum (2001) 1.05
Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol (2010) 1.05
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer (2009) 1.04
Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis (2006) 1.04
Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabet Med (2009) 1.04
Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med (2007) 1.02
The aminoacyl ribonucleic acid synthetases. I. Properties of the threonyladenylate-enzyme complex. J Biol Chem (1966) 1.01
Evaluation and management of nonsyndromic craniosynostosis. Acta Paediatr (2011) 1.01
ALS patients and caregivers communication preferences and information seeking behaviour. Eur J Neurol (2007) 1.00
Benign intracranial hypertension after minocycline therapy. Eur Neurol (1978) 0.99
Walther Riese, 1890-1976. J Hist Med Allied Sci (1977) 0.97
Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension (1995) 0.97
Fatal hyperpyrexia after withdrawal of levodopa. Neurology (1984) 0.97
Chronic alcohol use and first symptomatic epileptic seizures. J Neurol Neurosurg Psychiatry (2002) 0.96
Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours. Pancreatology (2008) 0.96
Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology (1976) 0.95
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants. Acta Neurol Scand (2008) 0.95
Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. J Neurol Neurosurg Psychiatry (2007) 0.95
Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: a prospective study. J Rheumatol (1987) 0.94
Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations. Immunopharmacology (2000) 0.93
Nutritional care routines in Italy: results from the PIMAI (Project: Iatrogenic MAlnutrition in Italy) study. Eur J Clin Nutr (2010) 0.93
Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new? World J Gastroenterol (2007) 0.93
HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry (2007) 0.93
Evaluation of Western immunoblotting technique in the serological diagnosis of human syphilitic infections. Eur J Epidemiol (1989) 0.92
Self-administered joint counts in rheumatoid arthritis: comparison with standard joint counts. J Rheumatol (1999) 0.91
Study of three sesquiterpene lactones from Tithonia diversifolia on their anti-inflammatory activity using the transcription factor NF-kappa B and enzymes of the arachidonic acid pathway as targets. Planta Med (1998) 0.90
Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS. J Neurol Neurosurg Psychiatry (2004) 0.90
Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer (1996) 0.90
Brucellar arthritis: a study of 39 Peruvian families. Ann Rheum Dis (1987) 0.90
Consolidation of massive bone allografts in limb-preserving operations for bone tumours. Int Orthop (1995) 0.90
3-Desoxyanthocyanidins from Arrabidaea chica. Phytochemistry (2001) 0.90